Trend-Following Backtester · Guide · backtest 한국어

equity · HK

Wuxi Biologics (Cayman) Inc. backtest

10 trend-following strategies were compared on the full daily history of Wuxi Biologics (Cayman) Inc.. 8 beat buy-and-hold CAGR; Supertrend ranks first by Sharpe, matching the main backtester. The return/drawdown alternative is Keltner 채널 돌파 (CAGR 26.3%, MDD -40.6%).

Data 2017-06-13 ~ 2026-07-31daily bars 2,249 (9.1 years)Costs 0.5%Venue HKEXMonthly snapshot 2026-07-31

Results by strategy

8 of 10 beat buy and hold (CAGR 16.7%, drawdown -93.0%).

Sharpe leader (same as main): Supertrend — CAGR 31.1%, MDD -47.5%, Sharpe 0.88, 56% exposure.

Return/drawdown alternative: Keltner 채널 돌파 — CAGR is 14.4%p higher than buy and hold, while drawdown improves by 45.5%p (CAGR 26.3%, MDD -40.6%, exposure 46%).

The alternative must retain 75% of buy-and-hold CAGR, improve drawdown by at least 20% and 5 percentage points, and stay below 95% exposure; the ranking weights return retention 60% and drawdown improvement 40%.

Strategy · parametersCAGRMDDSharpeCalmarTotalTradesExposure
Supertrend
period=16, mult=3.8
31.1%-47.5%0.880.6611.9x2556%
ADX / DI 방향성
period=38, threshold=8
28.8%-51.1%0.870.5610.1x6951%
EMA 크로스오버
fast=24, slow=53
29.5%-52.7%0.850.5610.6x2558%
Keltner 채널 돌파
emaPeriod=61, atrPeriod=20, mult=1.3
26.3%-40.6%0.840.658.5x3746%
SMA 크로스오버
fast=23, slow=75
28.1%-48.5%0.820.589.6x2356%
볼린저 밴드 돌파
n=56, k=0.8
24.8%-47.2%0.790.527.5x4149%
ROC 모멘텀
n=124, threshold=0.13
22.1%-50.9%0.730.436.2x5649%
Donchian 채널 돌파
entryN=117, exitN=61
21.3%-48.2%0.710.445.8x850%
Parabolic SAR
step=0.02, maxStep=0.06
6.2%-74.5%0.350.081.7x13453%
MACD
fast=16, slow=33, signal=16
-4.4%-83.5%0.10-0.050.7x12553%
Buy and hold16.7%-93.0%0.570.184.1x1100%
1x 10x 2018 2020 2022 2024 2026 SupertrendBuy and hold
Supertrend: Solid strategy line versus dashed buy-and-hold line. Log scale.
0% -23% -46% -70% -93% 2018 2020 2022 2024 2026 Buy and holdSupertrend
Supertrend maximum drawdown -47.5% (2023-01-16 → 2024-09-23), recovered after 988 days.

Rules of the top strategy

Trades the direction of a volatility-based trend line that trails below/above price.

Method and caveats

Past performance does not guarantee future returns. Parameters were selected on the same full-history sample using sharpe over 40 trials per strategy, so results contain in-sample bias. 0.5% trading costs are included; taxes, slippage and rejected orders are not.
Re-run the same setupAll asset reports

Read next